fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

85% of Americans want animal experiments phased out, new survey shows

Written by | 6 Oct 2024

A new survey shows that Americans’ attitudes toward experiments on animals have changed significantly in recent years, with the vast majority now favoring phasing out animal experiments in… read more.

Ontario Institute for Cancer Research funding aims to speed the development of new drugs for some of the most common cancers

Written by | 4 Oct 2024

The Ontario Institute for Cancer Research (OICR) continues to support Ontario drug discovery research by funding high-quality investigations of new therapies for some of the most prevalent pediatric… read more.

It’s the most common STI you’ve never heard of. Will this newly developed drug provide the cure?

Written by | 1 Sep 2024

Researchers at Tulane University are leading a groundbreaking study to seek a more effective treatment for trichomoniasis, an infection that, despite being the most common curable sexually transmitted… read more.

Biotechnology companies can sustain the pipeline of new drugs under the Inflation Reduction Act

Written by | 27 Jul 2024

New research from the Center for Integration of Science and Industry at Bentley University shows that differences between the financial structures of large pharmaceutical producers and smaller, emerging biotechnology companies creates synergies… read more.

Purdue pharmacy researcher receives $2.4 million NIH grant to fight antimicrobial-resistant lung infections

Written by | 8 May 2024

Qi “Tony” Zhou, a researcher in Purdue University’s College of Pharmacy has received a $2.4 million grant from the National Institutes of Health to fight lung infections that have established… read more.

Green light for 12 new medicines from EU watchdog

Written by | 8 Apr 2024

The European Medicines Agency (EMA) has recommended the approval of twelve new products, following reviews by its key human medicines committee (CHMP). This brings to twenty-five the number… read more.

US drug approvals 2010-2019 align with US, but not global, burden of disease; expedited approval programs may make the gap worse

Written by | 17 Mar 2024

Drug approvals in the United States between 2010-2019 were aligned with the US, but not global, burden of disease and the increasing number of expedited drug approvals could… read more.

BU researchers describe new technological platform to accelerate drug development

Written by | 29 Feb 2024

Drug development is currently an extremely long, expensive and inefficient process. Findings generated in a lab are often very hard to replicate once translated into animal models or… read more.

Using AI to create better, more potent medicines

Written by | 2 Jun 2023

While it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, a new study suggests that using generative artificial intelligence… read more.

Journal of Pharmaceutical Analysis studies shine the light on advancements in pharmaceutical analytical techniques and overcoming chemoresistance

Written by | 1 Jun 2023

Research into new drug development is ongoing at a very fast pace globally. In keeping with newer remedies entering the market, there is a need for optimizing existing… read more.

University of Limerick, Ireland research could reduce time required to bring new medicines to market

Written by | 12 Jul 2022

Researchers at University of Limerick in Ireland have developed a new modelling approach to pharmaceutical manufacturing that could reduce the time required to bring v. Professor Gavin Walker… read more.

New study shows genes can predict response to arthritis treatment and paves the way for future drug development

Written by | 31 May 2022

New research from Queen Mary University of London, published in Nature Medicine, has shown that molecular profiling of the diseased joint tissue can significantly impact whether specific drug treatments will… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.